Publication | Open Access
Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial—EPOC 2 (JFMC49-1601-C5)
14
Citations
47
References
2021
Year
The study findings demonstrate that an ED can prevent OM in patients with esophageal cancer receiving chemotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1